Potential treatment for selected neurological disorders By interacting with receptors in the nervous system, VIP supports neuronal survival, reduces oxidative stress, and mitigates neuroinflammation, which are key factors in the progression of disorders like Alzheimers, Parkinsons, and multiple sclerosis (9)
Some haplotypes also appear to be less resistant to EBV infection, such as DR2-DQ6, DR3-DQ2, and DR4-DQ8, making them more likely to develop EBV-related disorders (90)
4.1 Clinical relevance of the CLP model The CLP model was selected for its unique ability to recapitulate core clinical features of SAE: polymicrobial sepsis, hippocampal neurodegeneration, and chronic cognitive impairment (Yin et al., 2023)
Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, Smith R, Lessnick SL, Sahasrabudhe S, Stockwell BR
Tirzepatide is metabolized through proteolytic cleavage and does not rely on cytochrome P450 enzymes, while sermorelin undergoes rapid enzymatic degradation in plasma
Aljawad et al., 2014